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S un'llTlary 
Heine uptake is a common means of iron and porphyrin acquisition by many pathogenic bac- 
teria. The genus Haemophilus includes several important pathogenic bacterial species  that char- 
acteristically require hemin-, protoporphyrin-, or heme-substituted proteins as essential growth 
factors under aerobic conditions.  However, the mechanism  of heine transport is not under- 
stood for Haemophilus.  We have cloned a DNA fragment from H.  influenzae that allows an Es- 
cherichia coli hemA mutant to employ exogenous heroin or protoporphyrin IX as sole sources of 
porphyrin. DNA sequencing of the cloned DNA fragment suggested that a previously charac- 
terized gene (hel) encoding an antigenic, outer membrane lipoprotein e(P4) was responsible for 
the complementation activity. Construction of hel insertion mutations in strain H.  influenzae 
P,.d demonstrated that hel is essential for growth under aerobic conditions but not under anaer- 
obic conditions. The aerobic growth defect of hel mutants could be reversed by providing ex- 
ogenous heroin in the presence of outer membrane perturbants suggesting that these hel mu- 
tants are defective in transport of hemin through the outer membrane. The analysis of hybrids 
between e(P4)  and [3-1actamase demonstrated that a domain of e(P4)  near its NH  2'  terminus 
was required for its function in heroin use. Within this domain is a short amino acid sequence 
that displays  similarity to H.  influenzae  hemin binding protein HbpA,  heroin-binding motifs 
present in eukaryotic transcription activator heine-activated protein, and the heine containing 
proteins hemoglobin  (c~-chain)  and  cytochrome C3,  suggesting that  this  region may be  in- 
volved in hemin binding and/or transport. 
H~ 
emophilus  influenzae  type b  is a  Gram-negative coc- 
obacillus,  responsible  for significant morbidity and 
mortality in young children  (1,  2).  Under aerobic condi- 
tions,  H.  influenzae  requires  two  essential  growth  factors: 
nicotinamide adenine dinucleotide (NAD) 1 and heroin (3). 
Hemin can serve as a source of  both iron and porphyrin for 
this microorganism. Protoporphyrin IX (PPIX) can substi- 
tute for the heroin requirement if an exogenous iron source 
is also available  (4, 5). Sanders et al. (6), recently character- 
ized  a  periplasmic  binding protein-dependent iron  trans- 
port system, encoded by the HitA,B,C components in H. 
influenzae which was required for uptake of iron citrate or 
ferric ions. Although H.  influenzae does not synthesize sid- 
erophores,  it  can  utilize  host  iron-binding  proteins  as 
sources of iron (7). For example, two H.  influenzae proteins 
encoded by tbpA,B have been shown to be essential for uti- 
lization of transferrin-derived iron (8). 
Hem_in or PPIX are taken up by H.  influenzae if present 
in  growth medium but both H.  influenzae  and H.  ducreyi 
1Abbreviations  used in  this paper: ALA, 5-amino-levulinic acid; BH1, brain 
heart  infusion;  HAP-l, heine-activated  protein;  LB, Luria broth;  NAD, 
nicotine adenine  dinucleotide;  PPIX, protoporphyrin. 
can  also  scavenge  heroin  from  certain  host  proteins  that 
contain heroin. Some of the bacterial components required 
for utilization  of various  heroin-containing  host  proteins 
have recently been characterized. For H.  influenzae type b, 
a hemopexin-binding complex has been characterized and 
consists  of three gene products Hxu A, B, and C  (9,  10). 
Another hemopexin receptor complex is thought to consist 
of three different outer membrane proteins with molecular 
masses of~29, 38, and 57 kD (11).  Outer membrane pro- 
teins that bind hemoglobin have also been characterized for 
H.  influenzae (12) and H.  ducreyi (13,  14). 
Although  H.  influenzae  can  grow  on  laboratory media 
containing free hemin or PPIX, there has been less progress 
in identifying the key components necessary for their utili- 
zation.  Two heroin-binding proteins have been reported. 
A  39.5-kD  outer membrane  protein  (15)  was  shown  to 
bind to hemin-agarose and this interaction was inhibited by 
heroin or hemin-binding proteins such as hemoglobin, but 
not  by  PPIX.  A  60.6-kD  heroin-binding  lipoprotein 
(HbpA), also  isolated from H.  influenzae  by affinity chro- 
matography, was found to display a high degree of homol- 
ogy to the periplasmic dipeptide transport protein DppA of 
Escherichia  coli (16).  The effects of mutations in  the genes 
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been reported. 
Given that no H.  influenzae mutants have been identified 
that are deficient in  the utilization  of heroin or PPIX as a 
porphyrin  source,  we  attempted  to  clone  genes  encoding 
components in this pathway using a genetic complementa- 
tion approach. In this report we present results that indicate 
that  the  H.  influenzae  outer  membrane  lipoprotein  e(P4), 
encoded by the hel gene, is an essential component for utili- 
zation of heroin, PPIX, or hemoglobin as exclusive sources 
of porphyrin.  The  hel  gene  was  identified  previously  by 
Green et al.  (17)  as  encoding the immunodominant  outer 
membrane  protein  e(P4).  Although  antigenically  highly 
conserved among both typable and nontypable H.  influen- 
zae isolates,  e(P4) had not previously been assigned any bi- 
ological function. 
Materials and Methods 
Bacterial Strains and Growth Condition.  E.  coli strain  MC4100 
hemA was obtained from G. Jander (Dept.  of Microbiology and 
Molecular  Genetics,  Harvard  Medical  School,  Boston,  MA), 
strain  H.  influenzae Rd was obtained from A. Wright (Dept.  of 
Microbiology, Tufts Medical School, Boston, MA), and H. influ- 
enzae type b Eagan was provided by G. Siber  (Harvard Medical 
School, Boston, MA) (18). The hemA- derivatives  ofE. coli-K12 
strain  MC4100  (F-  araD A(argF-lac)U69  rpsL150  relA1  deoC1 
ptsF25flbB5301  rbsR) (19)  were  grown  on  Luria broth  (LB) 
medium  supplemented  with  50  I~g/ml  5-amino-levulinic  acid 
(ALA) at  37~  under aerobic  conditions.  H.  influenzae  type b 
Eagan and H. it~fluenzae Rd were grown on 3.8% brain  heart in- 
fusion  (BHI)  agar (Difco Laboratories,  Inc., Detroit, MI) supple- 
mented  with  10  F~g/ml each  of NAD,  and heroin-chloride  or 
PPIX (all from Sigma Chemical Co., St.  Louis,  MO)  (20). Hae- 
mophilus strains  were  grown  under  anaerobic  conditions  using 
GasPak  150  TM,  in  a  BBL  GasPak  Plus  generator  with  catalyst 
(Baxter Healthcare Corporation, Medford, MA). 
Genetic Methods, Plasmids and Transposon Mutagenesis.  Chromo- 
somal DNA of H.  influenzae strains was prepared by the method 
of Barack  et  al.  (20). Plasmid  DNA preparation was carried  out 
according to the Qiagen kit protocol (Qiagen, Inc., Studio City, 
CA).  Cloning and  restriction  analyses were  done according to 
Maniatis et al. (21). Hasmid pACYC184 (22, 23) was used in the 
construction of a genomic DNA library  of H.  influenzae type b. 
Briefly,  chromosomal  DNA  from  strain  H.  influenzae  type  b 
Eagan was partially digested with restriction  enzyme Sau3AI, pu- 
rified  by  gel  electrophoresis  and  ligated  into  BamHI-digested 
pACYC184.  Hasmid pACYC177  (22, 24)  was  used  as control 
plasmid  for the expression  of native [3-1actamase in immunoblot 
analyses (see below). 
PCR amplification  of the  hel gene DNA fragment was per- 
formed using the GeneAmp DNA amplification  kit, according to 
the Perkin-Elmer/Cetus  Corp.  (Emeryville,  CA) thermal DNA 
cycler protocol, based on Mullis and Faloona (25). The following 
specific primers were used  for the amplification  of the hel gene 
DNA  fragment:  AR15  (26'  mer):  5'-ATTGGATCCGAAT- 
TCTTAAAAGGAAT-3'; and  AR16  (30'  mer):  5'-ATTAA- 
ATATTGGATCCAGTAAAAACTGAGC-3'. These  oligonu- 
cleotides were designed to anneal to the flanking DNA sequences 
of the hel gene at bp position 1-18 for AR15, and 1032-1047 for 
AR16, according to the DNA sequence published  by Green et al. 
(17). BamHI restriction  sites were designed  into the 5' ends  of 
primers AR15 and AR16. 
Southern blot analysis (26) employed the enhanced chemilu- 
minescent detection system  (ECL;  Amersham Corp.,  Arlington 
Heights,  IL) as described  by the manufacturer. Electroporation or 
transformation of plasmid  or linear  DNA into H.  influenzae Rd 
was accomplished using the method of Mitchell  et al.  (27) and 
Tomb et al. (28). 
Mini transposon TnlOd-bla  (29) was used  to construct hybrid 
fusion  proteins between e(P4) and 13-1actamase. Plasmid pJR207 
was used to mutagenize plasmid pJRP4 as described  earlier  (29). 
The insertion sites of the Tn IOd-bla element were determined by 
the dideoxy nucleotide chain termination method ofSanger et al. 
(30), and performed with  the automatic  sequencing method  of 
Applied Biosystems Inc. (Foster City, CA). Synthetic oligonucle- 
otide AR6 is an antiparallel  16' mer primer of the 5' end of the 
blaM gene, and was used as DNA-sequencing primer to detect fu- 
sion joints of Tn I Od-bla insertions  as described  earlier (29). 
Western Blot Analysis.  Derivatives  of E.  coli strain  MC4100 
hemA  carrying  either  plasmid  pACYC177,  pJRH1,  or  pJRP4 
were grown in 30 ml LB at 37~  for 18 h.  Cells were harvested 
by  centrifugation,  washed  twice,  and  resuspended  in  NaPO4 
buffer  (100  mM,  pH,  7.4).  Fivefold  concentrated  suspensions 
were disrupted  by sonication,  and the extracts obtained were ana- 
lyzed by electrophoresis  in  11% polyacrylamide gels containing 
sodium dodecylsulfate  (31). Separated proteins were transferred  to 
nylon membranes  (32), and subsequently  probed with  antibody 
directed against BlaM as described  in Reidl and Mekalanos  (29). 
Results 
Isolation  and  Identification  of the  H.  influenzae  e(P4)  Gene 
Product.  To identify specific heroin uptake components of 
H.  influenzae,  we used complementation of an E.  coli K12 
strain  MC4100  hemA  mutant.  The  hemA  gene  encodes 
Glu-tRNA-reductase,  the  enzyme that initiates  porphyrin 
synthesis by the alternative C5-pathway (33) and is respon- 
sible for the synthesis of ALA from Glu-tRNA (34, 35). E. 
coli hemA  mutants  are  unable  to  grow  aerobically  unless 
ALA is provided in the growth medium.  Medium supple- 
mented with heroin does not support growth of hemA mu- 
tants because the E. coli K12 outer membrane is imperme- 
able to extracellular hemin or PPIX (36). Accordingly, we 
expected H.  influenzae genes encoding herrfin utilization to 
complement hemA mutants of E. coli for growth on heroin 
or PPIX as sole porphyrin sources. A  similar approach for 
the cloning of heroin utilization genes has recently been de- 
scribed by Stojiljkovic and Hantke (37). 
Competent  cells  of strain  MC4100  hemA  were  trans- 
formed  with  an  H.  influenzae  genomic  plasmid  library. 
Transformed cells were plated onto LB agar plates contain- 
ing  ALA  (50  p~g/ml),  and  kanamycin  (20  p~g/ml).  After 
overnight  incubation  at  37~  the  colonies  were  replica 
plated  onto  LB  agar plates  containing heroin  (10  I~g/ml) 
and kanamycin (20 p~g/ml).  Several colonies that grew on 
the  latter  medium  were  purified  and  their  plasmid  DNA 
isolated.  Retransformation  into  MC4100  hemA  showed 
that plasmid pJRH1  was responsible for a heroin utilization 
phenotype. 
Restriction and Southern blot analysis ofplasmid pJRH1 
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DNA.  Sequence analysis of the entire 1-kb insert revealed 
the presence of ~400 bp of DNA that was identical to the 
5' end of the hel gene previously reported to encode outer 
membrane  protein  e(P4)  (17).  The  sequence  analysis  re- 
vealed that the coding sequence for the NH2-terminal 69 
amino  acid  residues  of e(P4)  were  fused to  a  coding se- 
quence for a H.  influenzae  homolog of the E.  coli gene tgt 
(tRNA  guanine  transglycosylase)  (38,  39).  Given  that  a 
Sau3AI  site  was  present at  the  fusion junction,  we  con- 
cluded  that  this  hybrid gene  was  the  result  of a  ligation 
event between different chromosomal Sau3Al DNA frag- 
ments that had occurred during the construction of the ge- 
nomic  library.  Nonetheless,  as  shown  in  Fig.  1,  pJRH1 
does  allow  strain  MC4100  hemA  to  utilize  heroin  and 
PPIX,  suggesting the  e(P4)  portion  of the  fusion protein 
encoded by pJRH1 was responsible for this phenotype. 
To investigate whether the full-length e(P4) protein was 
also  capable  of complementing strain  MC4100  hemA  for 
heroin utilization, we subcloned the complete hel gene fi:om 
the chromosome of H.  influenzae type b Eagan using PCR. 
Synthetic oligonucleotides AR15 and AR16 were designed 
based on the published sequence of the hel gene (17); a sub- 
sequent  PCR  reaction  using  H.  influenzae  chromosomal 
DNA  as  the  template  produced  a  900-bp  product.  This 
PCR  product  was  digested  with  BamHI  and  subcloned 
into the BamHI restriction site ofplasmid pACYC184 pro- 
ducing plasmid pJRP4. DNA sequence analysis confirmed 
that pJRP4 encoded the entire hel gene (data not shown). 
As shown in Fig.  1, pJRP4 was also capable of comple- 
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Figure  1.  Growth analysis ofMC4100 hemA transformants. Growth of 
different E.  coli transforrnants were  monitored after overnight growth. 
Strain MC4100 hemA was transformed with plasmids pJRP4, pJRH1, and 
control plasmid pACYC184.  The strains were grown on LB containing 
chloramphenicol (15  ~g/ml), and supplemented with heroin, PPIX, and 
ALA at the concentrations indicated below the graph. The cell density of 
overnight growth was measured optically at 600 nm. 
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although  growth  was  somewhat  less  than  that  seen  for 
pJRH1.  However, E.  coli strains  carrying pJRP4 produce 
smaller colonies on LB agar plates containing ALA (50 I~g/ 
ml)  as  well,  suggesting  that  the  expression  of the  entire 
e(P4) gene product is deleterious to E. coli and thus reduces its 
growth rate and yield regardless  of the source ofporphyrin. 
Isolation  and  Characterization  of Tn l Od-bla Insertions  in  the 
hel Gene.  To obtain further evidence for the role of the 
hel gene in heine utilization, we performed transposon mu- 
tagenesis  of hel with the mini transposable element TnIOd- 
bla (29). Insertion of  this transposon into the correct reading 
frame of a gene encoding an exported protein can produce 
a hybrid protein that encodes resistance to ampicillin. Ac- 
cordingly, plasmid pJR207 was used as a source of TnlOd- 
bla in mutagenesis protocol ofpJRP4 similar to that previ- 
ously described (29). After selection for ampicillin-resistant 
colonies  in  a  strain  carrying  both  pJR207  and  pJRP4, 
plasmids  were prepared and retransformed to confirm link- 
age  of [3-1actamase activity to  the  pJRP4-1inked  marker, 
chloramphenicol resistance. 
The locations of the TnlOd-bla insertions on pJRP4 were 
determined by DNA  sequence analyses.  Seven TnlOd-bla 
insertions  were  identified  within  the  hel  gene  (data  not 
shown). Fig.  2 shows the positions of insertions number 9 
and  34,  encoded  by  plasmids  pJRP4/9  and  pJRP4/34. 
Western blot analysis  showed that plasmids  pJRP4/9  and 
pJRP4/34  encoded ~-lactamase fusion proteins of 30 and 
36  kD,  respectively (data  not  shown).  Given  that  native 
J3-1actamase migrates at "-'28 kD, the sizes of these ~-lacta- 
mase fusion proteins correspond to the defined position of 
Tn lOd-bIa insertions within the hel gene as shown in Fig. 2. 
Growth  studies  of strain  MC4100  hemA  transformed 
with the recombinant plasmids  pJRP4, pJRH1, pJRP4/9, 
and pJRP4/34 were conducted. The ability to utilize heroin 
(10 I~g/ml) or PPIX (10 ~g/ml) for growth was observed 
for cells harboring plasmids  pJRP4, pJRH1, or pJRP4/34, 
but not for plasmid pJRP4/9, which encodes 50 amino ac- 
ids of the original e(P4)  protein (Fig.  2).  All transformants 
were able to grow in the presence of ALA (50 }xg/ml), sug- 
gesting that the plasmid-linked defects in heroin and PPIX 
utilization were related to the position of the TnlOd-bla in- 
sertion within the hel gene rather than a nonspecific growth 
inhibition. Thus, only plasmids  pJRH1  and pJRP4/34 al- 
lowed utilization of heroin and PPIX and these two plas- 
raids maintained the coding sequence for the first 49 and 
91 amino acids ofe(P4), respectively (Fig. 2). It is interest- 
ing to note that homology searches of the GenBank data- 
base  for the  first  90  amino  acids  of e(P4)  resulted in  the 
identification of  a short amino acid motif, KVAFDH, which 
was found to be present in degenerate form in several char- 
acterized heroin-binding or heroin-associated proteins. As 
shown in Fig.  2,  the KVAFDH motif is located at amino 
acid  position  65  in  e(P4),  and  is  thus  largely  contained 
within the  e(P4)-specific sequences remaining in  the  two 
functional fusion proteins encoded by plasmids  pJRP4/34 
and pJRH1. 
Construction  and  Characterization  of hel Insertion  Mutations 
in H.  influenzae.  To  confirm  that  e(P4)  is  involved  in E. eoli 
hemin- 
growth 
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Figure  2.  Similarity of e(P4) to  herren-binding 
proteins. (Top) The amino acid sequence in single 
letter code of a portion of the NH2'-ternfinal re- 
gion of e(P4). (Bottom) The  residues of e(P4) re- 
maining in  fusion proteins encoded by plasmids 
pJRH1, pJRP4/9, and pJRP4/34. The sequence is 
aligned with short segments of homologous amino 
acid residues from heroin-binding proteins HbpA, 
HAP-l, hemoglobin (x chain, and cytochrome C3. 
(:)  Identity to  e(P4); (+)  conserved amino acids. 
(Le3~) The growth phenotype of E. coil hemA strains 
(carrying the indicated plasmids) on heroin (10 ~g/ 
ml)-supplemented media. 
hemin  uptake,  we  constructed  insertion  mutations  in  the 
hel gene  of strain  H.  influenzae  Rd.  Plasmid pJRP4/9  and 
pJRP4/34  DNA  were  prepared  and  then  linearized  with 
restriction  endonuclease  BamHI  to  produce  linear  mole- 
cules  in  which  the  corresponding  TnlOd-bla  insertions 
were  flanked  by  H.  influenzae  chromosomal  DNA  se- 
quences.  These  DNA  fragments  were  introduced  into 
strain  H.  influenzae  Rd  by  electroporation.  After  3  h  of 
phenotypic  expression,  cells  were  plated  on  BHI  agar 
plates,  containing NAD (10 p~g/ml), and ampiciUin (5  ~zg/ 
ml).  Critically,  the  plates  were  incubated  at  37~  under 
anaerobic  conditions  to  circumvent  the  presumed  hem_in 
requirement  of the desired recombinants.  Ampicillin-resis- 
tant  colonies  were  observed  within  2  d,  and  one  colony 
from each  electroporation  was  purified  for Southern  blot 
analysis. 
Chromosomal DNA was prepared from isolated amp  r H. 
influenzae  Rd  colonies,  REI1009  (hel(9)::TnlOd-bla)  and 
REI1034  (helO4)::TnlOd-bla),  and  also  from  wild-type 
strains  H.  influenzae  type  b  Eagan,  and  H.  influenzae  Rd. 
Figure 3.  Southern blot analysis 
of  H.  influenzae  hel  mutant 
strains. Chromosomal DNA was 
digested with  restriction endo- 
nuclease BamHI, separated on an 
agarose gel, and  transferred to 
nylon membrane. DNA was pre- 
pared from H.  influenzae type b 
Eagan (lane 1), H. influenzae Rd 
(lane 2), REI1009 (lane 3), and 
REI1034  (lane  4).  (A)  Mem- 
brane probed with hd gene--spe- 
cific  probe.  (B)  Membrane 
probed with  blaM gene~pecific 
probe. 
After digestion  with  BamHI,  DNA  fragments  were  sepa- 
rated by gel electrophoresis,  transferred to membranes,  and 
then  hybridized  against  hel-  or blaM-specific  gene  probes. 
As shown in Fig. 3, the hel gene probe hybridized to a 9-kb 
fragment  derived  from the  two  wild-type  strains  (lanes  1 
and 2) whereas  the two amp  r strains  displayed hybridizing 
fragments of~10  kb in size (lanes 3 and 4). The increase in 
size of these  10-kb fragments  corresponds  to the presence 
of Tn lOd-bla insertions  (Tn lOd-bla,  850 bp)  in the hel loci 
of strains  REI1009  and REI1034,  as indicated by hybrid- 
ization  of the  same  fragments  to  the  blaM-specific  probe 
(Fig.  3).  From these  data,  we conclude that hel::TnlOd-bla 
insertions 9 and 34 have been successfully recombined onto 
the  chromosome  of  strains  H.  influenzae  REI1009  and 
REI1034. 
In contrast to anaerobic conditions, strains REI1009 and 
REI1034 do not grow on BHI agar plates containing NAY) 
(10  p~g/ml),  and  heroin  (10  ~g/rnl),  when  incubated  at 
37~  under  aerobic  conditions  (Fig.  4  A).  These  two 
strains also do not form single colonies under aerobic con- 
ditions  when  hemoglobin  (200  ~zg/ml)  or PPIX  (10  p~g/ 
ml) are used as sole sources of heine (Fig. 4 A). By compar- 
ison, wild-type strain H.  influenzae  Rd grows rapidly under 
these  same  aerobic  conditions  and  forms  single  colonies 
within 2 d. When strains  REI1009, REI1034, and H. influen- 
zae  Rd  were  inoculated  in  BHI  liquid  growth  medium 
containing NAD (10 ~zg/ml) and heroin (10 p~g/ml), growth 
was observed for the wild-type strain under aerobic condi- 
tions but not for the  hel insertion mutant strains  REI1009 
or  REI1034  (data  not  shown).  To  test  directly  whether 
e(P4) could complement the heme-dependent growth phe- 
notype  of  a  hel::TnIOd-bla  insertion  mutant,  we  trans- 
fornaed RE11009 with plasmid pJRP4. Transformants were 
then tested for their ability to grow aerobically in BHI liq- 
uid  growth  medium,  containing  NAD  (10  ~g/ml),  and 
heroin  (10  ~g/ml).  As  shown  in  Fig.  4  B,  H.  influenzae 
strain REI1009 transformed with pJRP4 was able to grow 
under  aerobic  conditions,  however  no  growth  was  ob- 
served for strain REI1009 when transformed with  control 
plasmid  pACYC184.  These  results  indicated  that  the  hel 
gene  product,  e(P4),  is  specifically required  for growth  of 
strain  Rd in  the  presence  of oxygen,  a  growth  condition 
under which H.  influenzae  is known to require  an exoge- 
nous source  of heme.  Given the ability  of the  hel gene  to 
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Figure 4.  Growth phenotypes of/-/, influenzae Rd hel mutant strains.  (A) 
Cells were grown on 3.8% BHI agar plates containing heroin (10 ~g/ml), 
PP1X  (10  ~g/ml),  or hemoglobin (200  ~g/ml and previously dialyzed 
overnight in 10 mM NaPO  4 buffer, pH 7.4) at 37~  under anaerobic and 
aerobic  conditions. Strains:  (W'I)  H.  influenzae Rd,  (9)  REI1009,  and 
(34)  R.EI1034.  (B) H.  influenzae strains  Rd and strain REI1009  carrying 
either pJRP4  or pACYC184  were  grown in  BHI-medium  containing 
heroin (10  b~g/rrtl) and NAD  (10  ~g/ml) at 37~  under aerobic condi- 
tions. Growth was monitored by optical density at 600 nm. Table 1.  Effect  of EDTA on Growth of H. influenzae Strains Rd 
and hel Mutant REI1009" 
[EDTA]  H. influenzae IKd*  REI1009* 
mM  OD600 
0  1.6  0.08 
0.001  1.7  0.35 
0.01  1.7  1.9 
0.1  1.3  1.4 
0.5  0.09  0.06 
l  0.06  0.06 
3  0.05  0.05 
*Strain H. influenzae 1Kd and REI1009 were grown in liquid BHI me- 
dium supplemented with heroin  (10  lag/ml),  NAD (10  Ixg/ml), and 
various concentrations of EDTA (0.001-3 raM). After overnight incu- 
bation  at 37~  under  aerobic conditions, growth was monitored by 
optical density at 600 nm. 
complement  E.  coli hemA  mutants for utilization  of heroin 
or PPIX,  these  data strongly suggest that e(P4)  is involved 
in heine uptake. 
Because  e(P4)  is known  to be an outer membrane pro- 
tein  (17),  we  reasoned  that  it  was facilitating  transport  of 
heine-related  compounds  across the  outer membrane.  To 
test whether  the  aerobic  growth  defect associated with  hel 
mutations was specifically associated with a defect in heroin 
or PPIX uptake, we attempted to complement the growth 
defect  of strain  REI1009  with  outer  membrane  pertur- 
bants.  As  shown  in  Table  l,  very  low  levels  of EDTA 
(0.001-0.1  raM) substantially stimulated the growth of strain 
REI1009  under  aerobic  conditions  in  the  presence  of 
hemin.  EDTA is known to disrupt the outer membrane of 
gram-negative bacteria,  and  thus  enhance  nonspecific  dif- 
fusion across this  membrane  (40).  The  growth stimulatory 
effect of EDTA  was  completely dependent  on  exogenous 
hemin,  and  furthermore,  other  outer  membrane  pertur- 
bants (e.g., polymyxin B) could substitute for EDTA in this 
assay (data not shown).  Thus,  we conclude  that the inabil- 
ity of the hel mutant strain REI1009 to grow under aerobic 
conditions  is specifically related to its inability  to transport 
hemin across its outer membrane. 
Discussion 
A  number  of different  pathogenic  microorganisms  are 
known  to utilize  heroin  as  a  source  of iron  or porphyrin. 
For  example,  Vibrio  cholerae can  utilize  iron  or  porphyrin 
derived  from  heroin  by  expressing  two  specialized  iron- 
regulated  components,  a  26-kD  inner  membrane  protein 
and  a 77-kD  outer membrane  protein  (41).  Similarly,  the 
heroin  uptake  system of Yersinia  enterocolitica consists  of an 
iron-regulated  outer membrane protein (37), and a specific 
periplasmic  binding  protein-dependent  transport  system 
(42).  Most recently, a cloned gene from Neisseria  meningiti- 
dis has been shown to be involved in the uptake of hemin 
and hemoglobin by this invasive pathogen  (43). 
Under aerobic conditions,  members of the genus Haemo- 
philus  such  as  H.  influenzae  classically  show  a  growth  re- 
quirement for the two essential supplements,  factors V  and 
X,  corresponding  to  NAD  and  heroin,  respectively  (3). 
Despite  the  fact  that  heroin  requirement  of H.  influenzae 
must be considered the most well known example of heine 
dependence,  the genes involved in this process have largely 
evaded genetic  analysis.  In this  report,  we  established  that 
the product of the hel gene (17), the outer membrane pro- 
tein  e(P4),  is one  of the  key components  involved  in  the 
utilization by H.  influenzae of hemin,  PPIX, and hemoglo- 
bin as sources of porphyrin. 
Previous  work  supports  the  roles  of several  other  gene 
products in mediating binding to and utilization  of heroin, 
hemopexin,  or hemoglobin  as heme sources in H.  influen- 
zae. For example, Cope et al.  (9) reported that mutants de- 
fective in hxuC are at least partially defective in heine  up- 
take  given  that  they  require  higher  levels  of heine  (in 
excess of 0.1  p,g/ml) to grow in liquid culture.  In addition, 
if hemoglobin  is used  as  porphyrin  source,  hxuC  mutants 
are still able to grow,  suggesting  that hemoglobin-derived 
heroin  can  be  utilized.  In  contrast,  the  strains  described 
here carrying insertion mutations in the  hel gene show vir- 
tually  no  growth  under  aerobic  conditions  even  in  the 
presence ofhemin  (10 lag/ml).  It is interesting to note that 
Wong  et al.  (11)  described  the  isolation  of a  hemopexin- 
binding receptor complex that included a component of 29 
kD  that  apparently  had  a  blocked  NH2-terminal  amino 
acid.  Given that e(P4) is about this size and is known to be 
a lipoprotein  (17), it is tempting to suggest that e(P4) is the 
29-kD  component  observed by Wong  et al.  Thus,  to  as- 
semble a high affinity heroin uptake system capable of rec- 
ognizing several different heme sources, e(P4) may need to 
interact  with  several  different  outer  membrane  compo- 
nents,  including  those  associated  with  the  hemopexin  re- 
ceptor  complexes  (9,  11).  The  fact  that  the  hel  gene  can 
complement an E.  coli hemA mutant for growth on  heroin 
and PPIX but not hemoglobin suggests that additional  fac- 
tors besides e(P4)  are needed to "strip" heroin from heine- 
associated proteins such as hemoglobin. 
The hel gene product was shown by Green et al.  (17)  to 
be an  outer  membrane lipoprotein  that is synthesized  as  a 
274-amino  acid  residue  precursor.  Surprisingly,  the  first 
clone  we  obtained  that  complemented  the  E.  coli hemA 
mutant  for growth  on  hemin  expressed  only  the  first  69 
amino  acids  of e(P4).  Subsequently,  TnlOd-bla  insertion 
analysis confirmed that as little as the first 90 amino acids of 
this protein could complement E. coli for hemin utilization. 
If one  assumes  normal  processing  and  maturation  of the 
e(P4) fusion proteins, plasmid pJRHI should encode a lipo- 
protein composed of only amino acids 21-69  of e(P4), yet 
still  be  capable  of complementation  of the  hemA  E.  coli 
mutant. 
In an attempt to further characterize the apparently func- 
tional  NH2'-terminal  domain  of e(P4),  we  compared  the 
first 80 amino acids of e(P4)  to entries in the GenBank da- 
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in  the  identification  of known  heroin-associated  proteins 
that shared limited similarities with  the  NH2-terminal re- 
gion of e(P4).  One  homology cluster was located around 
amino acid position 56-69--the same region that we found 
to be apparently critical for hemin utilization  as measured 
by growth complementation assays. Among those proteins 
that displayed some similarity to e(P4)  was the H.  influenzae 
HbpA protein,  a  henfin-binding lipoprotein  characterized 
by Hanson et al.  (16).  It is interesting that HbpA is highly 
homologous to the dipeptide transport protein DppA of E. 
coli (45).  Recently,  DppA has been implicated in  the  up- 
take  of ALA in  E.  coli (46).  Two  other hemin-associated 
proteins,  hemoglobin  (47)  and  cytochrome  C3  (48),  also 
showed  some  homology to  e(P4)  in  this  region  as  did  a 
eukaryotic  transcription  factor  heine-activated  protein 
([HAP]-1) known to bind heroin (49).  In the latter case, the 
homology  noted  corresponded  to  a  hexa-peptide  motif 
KVAFDH of e(P4)  (amino acid residues  64--69),  which is 
similar  to  the  "heine  regulatory  motiff"  (KCPVDH) 
present  in  multiple  copies  within  HAP-1  and  as  well  as 
other heme-binding proteins (49).  It is tempting to specu- 
late that the KVAFDH motif is essential for e(P4)  function, 
perhaps acting as a hem_in- or PPIX-binding site. 
It is  clear from our data that e(P4)  undoubtedly acts by 
facilitating the transport or diffusion of heroin-related com- 
pounds  through  the  outer membrane.  Nonlethal  concen- 
trations  of the  chelator  EDTA  and  the  antibiotic  poly- 
myxin B  can substitute for the loss of e(P4)  in H.  influenzae 
hel insertion  mutants  when  they are  grown  aerobically in 
the presence of heroin.  Given that the effect of EDTA and 
polymyxin B  on  these  mutants  most likely involves their 
ability to disrupt the  outer membrane permeability barrier 
(40),  these results suggest that e(P4) functions specifically by 
facilitating  the  transport  or  diffusion  of hemin  across  the 
cell's outer membrane. It is interesting to note that within 
the NH2-terminal region of e(P4)  there is a highly cationic 
segment (amino acids 54-78) in which there are eight pos- 
itively charged  amino  acid  residues  with  only  one  nega- 
tively  charged  residue.  Recently,  Hoess  et  al.  (50)  have 
presented  results  suggesting that  a  highly cationic loop  of 
the  LPS-binding  protein  limulus  antilipopolysaccharide 
factor (LALF) interacts with lipid A in much the same way 
as the cationic peptide antibiotic polymyxin B. Perhaps the 
cationic region of e(P4)  noted above plays a similar role in 
binding lipid A  and thus facilitates a localized disruption of 
the  outer  membrane  in  the  vicinity  of bound  heroin  or 
PPIX. 
Recently, Fleischmann et al.  (39)  reported the complete 
nucleotide sequence of H.  influenzae  strain Rd.  It is inter- 
esting to note that the hel gene (HI0693) is apparently not 
located within an operon nor is it closely linked to another 
gene  that  encodes  a  product  known  to  be  involved  in 
heine  or iron  acquisition.  However, we note  that  a  dyad 
repeat sequence  TTTTCAATTGAAAA is  located  62  bp 
upstream of the hel gene and hypothesize that this sequence 
may be involved in  regulation  of het  expression.  This se- 
quence is located in only one other place in the entire H. 
influenzae  genome  (position  1,558,736  bp).  The  second 
copy of the dyad repeat is near a gene cluster that includes a 
gene  (HI1471)  (39)  that  encodes  a  product  that  is  highly 
homologous  to  HemU,  an  inner  membrane  heine  per- 
mease  of  Yersinia  enterocolitica (42).  This  putative  operon 
also includes several other genes of  which two (HI1470 and 
HI1472) apparently encode inner membrane transport and 
periplasmic  binding  proteins.  Thus,  these  gene  products 
may  constitute  part  of  a  cytoplasmic  membrane  heine 
transport system that is coordinately regulated with het. 
Green et al.  (17)  originally reported the identification of 
the  hel  gene  product  as  the  outer  membrane lipoprotein 
e(P4)  and  found  that  it  was  antigenically  well  conserved 
among H.  influenzae  type b,  as well as among nontypable 
H.  influenzae  strains.  These authors also  demonstrated that 
anti-e(P4) polyclonal serum is bactericidal to clinical isolates 
of H.  influenzae,  but could not establish any other biologic 
function for e(P4).  Given the essential role of e(P4) in heine 
uptake,  it  is  not  too  surprising  that  antibodies  directed 
against this protein might be deleterious for H.  influenzae. 
Thus,  our data  support the  use  of e(P4)  as an antigen  for 
evaluation in  future vaccines for nontypable H.  influenzae 
and possibly other Haemophilus  species. 
We thank A. Wright for providing strain H. influenzae Rd, and also for his helpful discussions. We also thank 
G. Jander for providing the E. coli  MC4100 hemA derivative and G. Siber for providing H. influenzae type b 
Eagan. For their careful reading of the manuscript, we thank M. Dziejman and K. Klose. 
J.  Reidl was supported  by the  German  National  Scholarship Foundation  (Studienstiftung des deutschen 
Volkes, BASF-Sonderprogramm). This work was supported by National Institute of Health grant AI-26289 
and a grant from the Shipley Institute of Medicine. 
Address correspondence to Dr. John J. Mekalanos, Department  of Microbiology and Molecular Genetics, 
Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115. 
Received for publication 28 August  1995. 
627  Reidl and Mekalanos References 
1.  Funkhouser, A., M.C. Steinhoff, andJ. Ward. 1991.  Haemo- 
philus  influenzae  disease  and  immunization  in  developing 
countries. Rev.  Infect.  Dis,  13:542-554. 
2.  Turk, D.C.  1984.  The pathogenicity of Haemophilus  influen- 
zae.J.  Med. Microbiol.  18:1-16. 
3.  Evans,  N.M.,  D.D.  Smith,  and A.J. Wicken.  1974.  Heroin 
and nicotinamide adenine dinucleotide requirements of Hae- 
mophilus, influenzae.J.  Med.  Microbiol. 7:359-365. 
4.  Granick,  S.,  and  H.  Gilder.  1946.  The  porphyrin require- 
ments of Haemophilus  influenzae and some functions of the vi- 
nyl and propionic acid chains ofheme.J.  Gen. Physiol. 30:1-13. 
5.  White, D.C.,  and S.  Granick.  1963.  Heroin biosynthesis in 
Haemophilus.J.  Bacteriol. 85:842-850. 
6.  Sanders, J.D., L.D. Cope, and E.J.  Hansen.  1994.  Identifica- 
tion of a locus involved in the utilization of iron by Haemo- 
philus influenzae.  Infect.  Immun.  62:4515-4525. 
7.  Schryvers, A.B., and S.  Gray-Owen.  1992.  Iron acquisition 
in  Haemophilus  influenzae:  receptor for human  transferrin. J. 
Infect.  Dis.  165:103-104. 
8.  Gray-Owen, S.D.,  S. Loosmore, and A.B. Schryvers.  1995. 
Identification and characterization of genes encoding the hu- 
man transferrin-binding proteins from Haemophilus  influenzae. 
Infect.  Immun.  63:1201-1210. 
9.  Cope, L.D., R. Yogev, U. Muller-Eberhard, and E.J. Hansen. 
1995.  A gene cluster involved in the utilization of both free 
heine and heme:hemopexin by Haemophilus  influenzae type b. 
J.  Bacteriol. 177:2644--2653. 
10. Hanson,  M.S.,  S.E.  Pelzel, J.  Latimer, U.  Muller-Eberhard, 
and E.J.  Hansen.  1992.  Identification of a  genetic locus  of 
Haemophilus  influenzae  type b  necessary for the binding and 
utilization of heine bound to human hernopexin. Proc. Natl. 
Acad.  Sci.  USA.  89:1973-1977. 
11. Wong, J.C.Y., R. Patel, D. Kendall, P.W. Whitby, A. Smith, 
J. Holland, and P. Williams. 1995. Affinity, conservation, and 
surface  exposure of hemopexin-binding proteins in Haemo- 
philus influenzae.  Infect. Immun.  63:2327-2333. 
12. Hickrnan, M., D. Morton, and T. Stull. 1993.  Isolation of a 
hemoglobin binding protein from Haemophilus  influenzae.  In 
Abstracts of the 93rd General Meeting of the American Soci- 
ety of Microbiology, Washington, DC. B-292:78. (Abstr.) 
13. Elkins, C. 1995.  Identification and purification of a conserved 
heine-regulated hemoglobin-binding outer  membrane  pro- 
tein from Haemophilus  ducreyi. Infect.  Immun.  63:1241-1245. 
14. Elkins, C., C.J. Chen, and C.E. Thomas. 1995.  Characteriza- 
tion of the hgbA locus encoding a hemoglobin receptor from 
Haemophilus  ducreyi. Infect.  Immun.  63:2194--2200. 
15. Lee, B.C. 1992.  Isolation of an outer membrane heroin-bind- 
ing protein of Haemophilus  influenzae  type b.  Infect.  Immun. 
60:810-816. 
16. Hanson,  M.S.,  C.  Slaughter,  and  E.J.  Hansen.  1992.  The 
hbpA  gene of Haemophilus  influenzae  type b  encodes a heme- 
binding lipoprotein conserved among heine-dependent Hae- 
mophilus  species.  Infect. Immun.  60:2257-2266. 
17. Green,  B.A., J.E.  Farley, T.  Quinn-Dey,  R.A.  Deich,  and 
G.W. Zlotnick. 1991.  The e (P4) outer membrane protein of 
Haemophilus  influenzae:  biologic activity of anti-e serum and 
cloning and sequencing of the structural gene. Infect.  Immun. 
59:3191-3198. 
18. Schreiber, J.R.,  V.A.  Barrus,  and  G.R.  Siber.  1985.  De- 
creased protective efficacy of reduced and alkylated human 
immune serum globulin in experimental infection with Hae- 
mophilus  influenzae type b. Infect.  Immun.  47:142-148. 
19.  Casadaban,  M.J.  1976.  Transposition  and  fusion  of the  lac 
genes  to  select promoters  in  Escherichia  coli using bacterio- 
phage lambda and mu.J. Mol.  Biol.  104:541-555. 
20. Barack, G.J., M.S.  Chandler, R.J.  Redfield, and J.F. Tomb. 
1991.  Genetic systems in Haemophilus  influenzae.  Methods En- 
zymoI.  204:321-342. 
21.  Maniatis, T., E.F. Frisch, and J. Sambrook. 1982.  Molecular 
Cloning. Cold Spring Harbor Laboratory, Cold Spring Har- 
bor, NY. pp. 97-148. 
22.  Chang,  A.C.Y.,  and  S.N.  Cohen.  1978.  Construction  and 
characterization of amplifiable multicopy DNA cloning vehi- 
cles derived from the P15A cryptic miniplasmid.  J.  Bacteriol. 
134:1141-1156. 
23.  Rose, R.E.  1988.  The nucleotide sequence  of pACYC184. 
Nucleic Acids Res.  16:355. 
24. Rose, R.E.  1988.  The nucleotide sequence of pACYC177. 
Nucleic Acids Res.  16:356. 
25.  Mullis,  K.B.,  and  F.  Faloona.  1987.  Specific  synthesis  of 
DNA in vitro via a polymerase chain reaction. Methods Enzy- 
tool.  155:335-340. 
26. Southern, E.M.  1975.  Detection of specific sequences among 
DNA fragments separated by gel electrophoresis.  J.  Mol.  Biol. 
51:503-517. 
27.  Mitchell, M.A., K. Skowronek, L. Kauc, and S.H. Goodgal. 
1991.  Electroporation of Haemophilus  influenzae  is  effective 
for transformation  of plasmid but  not  chromosomal DNA. 
Nucleic Acids Res.  19:3625-3628. 
28.  Tomb, J.F., G.J. Barack, M.S.  Chandler, R.J. Redfield, and 
H.O. Smith. 1989. Transposon mutagenesis, characterization, 
and cloning of transformation genes of Haemophilus  influenzae 
Rd.J. Bacteriol. 171:3796-3802. 
29.  Reidl, J., andJ.J. Mekalanos. 1995.  Characterization of Vibrio 
cholerae bacteriophage K139 and use of a novel mini transpo- 
son to identify a phage-encoded virulence factor. Mol.  Micro- 
biol. 18:685-701. 
30. Sanger, F., S.  Nicklen, and A.R.  Coulson.  1977.  DNA se- 
quencing with chain-terminating inhibitors. Proc. Natl.  Acad. 
Sci.  USA.  74:5463-5467. 
31.  Laemmli, U.K.  1970.  Cleavage of structural proteins during 
the assembly of the head of bacteriophage T4. Nature (Lond.). 
227:680-685. 
32. Twobin,  H.,  T.  Staehlin,  and J.  Gordon.  1979.  Electro- 
phoretic transfer of proteins. Proc. Natl.  Acad.  Sci.  USA.  76: 
4350-4354. 
33. Jahn,  D., E. Verkamp, and D.  $611. 1992.  Glutamyl-transfer 
RNA:  a  precursor  of heine  and  chlorophyll biosynthesis. 
Trends  Biochem.  Sci.  17:215-218. 
34. Powell,  K.A., R.  Cox,  M.  McConville, and  H.P.  Charles. 
1973.  Mutations affecting porphyrin biosynthesis in  Escheri- 
chia coli. Enzyme.  16:65-73. 
35. Verkamp,  E.,  and B.K.  ChUm.  1989.  Isolation, nucleotide 
sequence,  and preliminary characterization of the Escherichia 
coli K-12 hemA gene.J. Bacteriol. 171:4728-4735. 
36. McConville, M.L., and H.P.  Charles.  1979.  Mutants of Es- 
cherichia coli K-12 permeable to haemin.J.  Gen. Microbiol.  113: 
165-168. 
37.  Stojiljkovic, I., and K. Hantke.  1992.  Heroin uptake system 
of Yersinia  enterocolitica: similarities with  other TonB-depen- 
dent  systems  in  gram-negative bacteria.  EMBO  (Eur.  Mol. 
Biol.  Organ.) J.  11:4359-4367. 
38.  Reuter,  K.,  R.  Slany,  F.  Ullrich,  and  H.  Kersten.  1991. 
Structure and organization of E.  coli genes involved in bio- 
628  Heroin Uptake in Haemophilus  influenzae synthesis of the deazaguanine derivative queuine,  a nutrient 
factor for eukaryotes.J. Bacteriol. 173:2256-2264. 
39. Fleischmann, R.D., M.D. Adams, O. White, R.A. Clayton, 
E.F. Kirkness, A.R.  Kerlavage, C.J.  Bult, J.F.  Tomb,  B.A. 
Dougherty, J.M.  Merrick, et al.  1995.  Whole-genome ran- 
dom sequencing and assembly of Haemophilus  influenzae  Rd. 
Science (Wash. DC). 269:496-512. 
40. Vaara, M.  1992.  Agents that increase the permeability of the 
outer membrane. Microbiol. Rev. 56:395-411. 
41. Henderson, D.P., and S.M. Payne.  1993.  Cloning and char- 
acterization of the  Vibrio cholerae genes encoding the utiliza- 
tion of iron from haemin and haemoglobin. Mol. Microbiol. 7: 
461-469. 
42. Stojiljkovic, I., and K.  Hantke.  1994.  Transport of haemin 
across  the cytoplasmic membrane through a haemin-specific 
periplasmic binding-protein-dependent transport  system  in 
Yersinia enterocolitica. Mol. Microbiol. 13:719-732. 
43. Stojiljkovic, I., V. Hwa, L. de Saint Martin, P. O'Gaora, X. 
Nassif, F. Heffron, and M. So. 1995. The Neisseria meningitidis 
haemoglobin receptor: its role in iron utilization and viru- 
lence. Mol. Microbiol. 15:531-541. 
44. Pearson, W.R., and D.J.  Lipman.  1988.  Improved tools for 
biological sequence comparison. Proc. Natl.  Acad.  Sci. USA. 
85:2444-2448. 
45.  Olson, E.R., D.S. Dunyak, L.M. Jurrs,  and R.A. Poonnan. 
1991.  Identification and characterization of dppA,  an Escheri- 
chia coli gene encoding a periplasmic dipeptide transport pro- 
tein.J. Bacteriol. 173:234-244. 
46. Verkamp, E., V.M. Backman, J.M. Bjoernsson, and D. Soell. 
1993.  The periplasmic dipeptide permease system transports 
5-aminolevulinic acid in Escherichia coli. J, Bacteriol. 175:1452- 
1456. 
47. Gorr, T., T. Kleinschmidt, and H. Fricke. 1991.  Close tetra- 
pod  relationships of the  coelacanth Latimeria indicated by 
haemoglobin sequences. Nature (Lond.).  351:394-397. 
48.  Pollock, W.B., M.  Loufti, M.  Bruschi, J.  Kapp-Giles, J.D. 
Wall, and G. Voordouw. 1991. Cloning, sequencing, and ex- 
pression of the gene encoding the high-molecular-weight cy- 
tochrome c from Desulfovibrio vulgaris Hildenborough. J. Bac- 
teriol. 173:220-228. 
49.  Zhang, L., and L. Guarente. 1995.  Heme binds to a short se- 
quence that serves a regulatory function in diverse proteins. 
EMBO (Eur. Mol.  Biol.  Organ,)J.  14:313-320. 
50.  Hoess, A., S. Watson, G.R. Siber, and R. Liddington. 1993. 
Crystal structure of an endotoxin-neutralizing protein from 
the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolu- 
tion. EMBO (Eur. Mol. Biol.  Organ.)J.  12:3351-3356. 
629  ReicU  and Mekalanos 